Actual Medicinal Product (AMP) -
Pharmorubicin 50mg/25ml solution for injection Cytosafe vials (Pfizer Ltd)
Name Details
|
Current Name
Pharmorubicin 50mg/25ml solution for injection Cytosafe vials
|
Start Date
26-02-2014
|
End Date
|
|
Previous Name
Pharmorubicin 50mg/25ml solution for injection vials
|
Start Date
21-01-2009
|
End Date
25-02-2014
|
|
|
Abbreviated Name
Pharmorubicin 50mg/25ml inj Cytosafe vials
|
Start Date
26-02-2014
|
|
Summary
- Licensed Route
- Intravenous, Intravesical
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| BNF |
|
Previous BNF
08010200
|
Start Date
23-06-2005
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 4853411000001102 |
05-09-2003 |
|
Actual Medicinal Product Pack (AMPP) Information